Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RYTM | IMCDY |
|---|---|---|
| Price | $92.45 | $53.45 |
| Change today | ▼ 0.41% | ▼ 0.65% |
| Market cap | $6.37B | $6.37B |
| Return, 3 months | -19.2% | +12.7% |
| Return, year to date | -13.6% | +20.3% |
| Return, 1 year | -5.5% | +0.7% |
| P/E (TTM) | -29.6 | 23.5 |
| P/B | 61.8 | 2.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 1.97% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 29 | 42 |
| 30-day volatility | 28.6% | 23.0% |
| Max drawdown, 1 year | -35.5% | -29.2% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.